221 related articles for article (PubMed ID: 33283625)
1. Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma.
Zhang L; Song M; Zhang F; Yuan H; Chang W; Yu G; Niu Y
J Histochem Cytochem; 2021 Mar; 69(3):165-176. PubMed ID: 33283625
[TBL] [Abstract][Full Text] [Related]
2. High stromal nicotinamide N-methyltransferase (NNMT) indicates poor prognosis in colorectal cancer.
Song M; Li Y; Miao M; Zhang F; Yuan H; Cao F; Chang W; Shi H; Song C
Cancer Med; 2020 Mar; 9(6):2030-2038. PubMed ID: 31989785
[TBL] [Abstract][Full Text] [Related]
3. Gastric Cancer With the Increased Nicotinamide N-methyltransferase-positive Stromal Cells Includes Unfavorable Prognosis-related Cancer-associated Fibroblasts.
Numakura S; Uozaki H
Anticancer Res; 2024 Apr; 44(4):1653-1660. PubMed ID: 38537979
[TBL] [Abstract][Full Text] [Related]
4. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.
Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç
J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726
[TBL] [Abstract][Full Text] [Related]
5. Nicotinamide N-methyltransferase overexpression is associated with Akt phosphorylation and indicates worse prognosis in patients with nasopharyngeal carcinoma.
Win KT; Lee SW; Huang HY; Lin LC; Lin CY; Hsing CH; Chen LT; Li CF
Tumour Biol; 2013 Dec; 34(6):3923-31. PubMed ID: 23838801
[TBL] [Abstract][Full Text] [Related]
6. Patients with low nicotinamide N-methyltransferase expression benefit significantly from bevacizumab treatment in ovarian cancer.
Li J; Yue H; Yu H; Lu X; Xue X
BMC Cancer; 2021 Jan; 21(1):67. PubMed ID: 33446144
[TBL] [Abstract][Full Text] [Related]
7. Expression profile and prognostic value of NNMT in patients with pancreatic cancer.
Xu Y; Liu P; Zheng DH; Wu N; Zhu L; Xing C; Zhu J
Oncotarget; 2016 Apr; 7(15):19975-81. PubMed ID: 26942567
[TBL] [Abstract][Full Text] [Related]
8. Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts.
Eckert MA; Coscia F; Chryplewicz A; Chang JW; Hernandez KM; Pan S; Tienda SM; Nahotko DA; Li G; Blaženović I; Lastra RR; Curtis M; Yamada SD; Perets R; McGregor SM; Andrade J; Fiehn O; Moellering RE; Mann M; Lengyel E
Nature; 2019 May; 569(7758):723-728. PubMed ID: 31043742
[TBL] [Abstract][Full Text] [Related]
9. NNMT Is an Immune-Related Prognostic Biomarker That Modulates the Tumor Microenvironment in Pan-Cancer.
Liu W; Zhu M; Li X; Er L; Li S
Dis Markers; 2023; 2023():9226712. PubMed ID: 36817086
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide N-methyltransferase protein expression in renal cell cancer.
Zhang J; Xie XY; Yang SW; Wang J; He C
J Zhejiang Univ Sci B; 2010 Feb; 11(2):136-43. PubMed ID: 20104648
[TBL] [Abstract][Full Text] [Related]
11. [Expression of nicotinamide-N-methyltransferase in gastric cancer and its biological and clinicopathological significance].
Wen Z; Liang W; Zhong Y; Sun F; Zhang Q
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jun; 41(6):828-838. PubMed ID: 34238734
[TBL] [Abstract][Full Text] [Related]
12. Expression of nicotinamide N-methyltransferase in hepatocellular carcinoma is associated with poor prognosis.
Kim J; Hong SJ; Lim EK; Yu YS; Kim SW; Roh JH; Do IG; Joh JW; Kim DS
J Exp Clin Cancer Res; 2009 Feb; 28(1):20. PubMed ID: 19216803
[TBL] [Abstract][Full Text] [Related]
13. Exosomal NNMT from peritoneum lavage fluid promotes peritoneal metastasis in gastric cancer.
Zhu AK; Shan YQ; Zhang J; Liu XC; Ying RC; Kong WC
Kaohsiung J Med Sci; 2021 Apr; 37(4):305-313. PubMed ID: 33508890
[TBL] [Abstract][Full Text] [Related]
14. Nicotinamide N-methyltransferase expression in squamous cell carcinoma of the vulva.
Çelik ZE; Akar S; Fındık S; Aytekin E; Çelik Ç
J Obstet Gynaecol; 2022 Aug; 42(6):2325-2330. PubMed ID: 35499473
[TBL] [Abstract][Full Text] [Related]
15. Nicotinamide N-methyltransferase enhances chemoresistance in breast cancer through SIRT1 protein stabilization.
Wang Y; Zeng J; Wu W; Xie S; Yu H; Li G; Zhu T; Li F; Lu J; Wang GY; Xie X; Zhang J
Breast Cancer Res; 2019 May; 21(1):64. PubMed ID: 31101119
[TBL] [Abstract][Full Text] [Related]
16. The Utility of Nicotinamide N-Methyltransferase as a Potential Biomarker to Predict the Oncological Outcomes for Urological Cancers: An Update.
Campagna R; Pozzi V; Spinelli G; Sartini D; Milanese G; Galosi AB; Emanuelli M
Biomolecules; 2021 Aug; 11(8):. PubMed ID: 34439880
[TBL] [Abstract][Full Text] [Related]
17. Nicotinamide
Holstein S; Venz S; Junker H; Walther R; Stope MB; Zimmermann U
Anticancer Res; 2019 Oct; 39(10):5427-5436. PubMed ID: 31570437
[TBL] [Abstract][Full Text] [Related]
18. Tumor stromal nicotinamide N-methyltransferase overexpression as a prognostic biomarker for poor clinical outcome in early-stage colorectal cancer.
Ogawa M; Tanaka A; Namba K; Shia J; Wang JY; Roehrl MHA
Sci Rep; 2022 Feb; 12(1):2767. PubMed ID: 35177765
[TBL] [Abstract][Full Text] [Related]
19. Analysis of nicotinamide N-methyltransferase in oral malignant melanoma and potential prognostic significance.
Mascitti M; Santarelli A; Sartini D; Rubini C; Colella G; Salvolini E; Ganzetti G; Offidani A; Emanuelli M
Melanoma Res; 2019 Apr; 29(2):151-156. PubMed ID: 30431528
[TBL] [Abstract][Full Text] [Related]
20. Nicotinamide N-methyltransferase: potential involvement in cutaneous malignant melanoma.
Ganzetti G; Sartini D; Campanati A; Rubini C; Molinelli E; Brisigotti V; Cecati M; Pozzi V; Campagna R; Offidani A; Emanuelli M
Melanoma Res; 2018 Apr; 28(2):82-88. PubMed ID: 29420365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
